❗️SEC recommended approval of Bedaquiline Tablet 20 mg for therapy of pulmonary tuberculosis (TB) due to multi-drug resistant mycobacterium TB in children without local clinical trial. ❓Why no proper RCT or even bridging study in India? Also see: https:
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis - Volume 23, Number 10—October 2017 - Emerging Infectious Disease journal - CDC https://t.co/qE7bqoZjCd via @CDCgov
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. https://t.co/ldVeDAbYAY https://t.co/amZ2OoIeXq
Off-Label Use of Bedaquiline in Children & Adolescents w Multidrug-Resistant #Tuberculosis https://t.co/K6ZPvX6W0l #TB MT @CDC_EIDjournal https://t.co/DDwPfaGmjP
A new study reports good treatment responses among children receiving #bedaquiline during #MDRTB treatment. https://t.co/UjAlg6YRe7 @msf_tb
Off-Label Use of Bedaquiline in Children & Adolescents w Multidrug-Resistant #Tuberculosis https://t.co/K6ZPvX6W0l #TB MT @CDC_EIDjournal https://t.co/ANWQLiJFyw
RT @3p4tb: It is important that new drugs for #TB are used in key populations. Data on Bdq in <18yrs https://t.co/WWxlbSvTqP .@msf_tb .@CDC…
RT @StopTB: New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfY…
RT @StopTB: New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfY…
RT @3p4tb: It is important that new drugs for #TB are used in key populations. Data on Bdq in <18yrs https://t.co/WWxlbSvTqP .@msf_tb .@CDC…
RT @3p4tb: It is important that new drugs for #TB are used in key populations. Data on Bdq in <18yrs https://t.co/WWxlbSvTqP .@msf_tb .@CDC…
It is important that new drugs for #TB are used in key populations. Data on Bdq in <18yrs https://t.co/WWxlbSvTqP .@msf_tb .@CDC_TB
RT @StopTB: New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfY…
RT @StopTB: New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfY…
RT @StopTB: New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfY…
New @CDC_EIDjournal "Off-Label Use of Bedaquiline in #Children & #Adolescents with Multidrug-Resistant #TB" https://t.co/RW7lfYhTJx https://t.co/d8Z1qP3GpH
Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/vMZCYlb3x7
MSF reports on the off-label use of #bedaquiline in children + adolescents with MDR-TB in its programs https://t.co/QRUdLur5Zw #TBResearch
RT @paimadhu: Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/…
RT @paimadhu: Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/…
RT @paimadhu: Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/…
RT @paimadhu: Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/…
Ahead of Print -Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/Q1iGZi4u4i
Nice to see our experience with #bedaquiline in kids online and open-access https://t.co/cPSACXU8Zn #TB
RT @MSFsci: Assessing the use of bedaquiline in children and adolescents with #MDRTB #DRTB #TB #bedaquiline https://t.co/OSCcFCjjmK via @CD…
Assessing the use of bedaquiline in children and adolescents with #MDRTB #DRTB #TB #bedaquiline https://t.co/OSCcFCjjmK via @CDCgov @MSF https://t.co/X7lOr0CBqZ
#Pediatric_tuberculosis https://t.co/6DZiCrbse5 Off-Label Use of #Bedaquiline in Children and Adolescents
RT @Mtb_papers: Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. https://t.co/5PCOnWxHOt htt…
.@CDC_EIDjournal : Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant #Tuberculosis https://t.co/MvU8HUSpB5 https://t.co/oswAtT5ROz
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. https://t.co/5PCOnWxHOt https://t.co/cpGYfEg1JB
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. https://t.co/ALngYM5bxY
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis https://t.co/fZW2ujiLmi